Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England [Scholarly Article - The Lancet, March 2022]

Title:

Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England

 

Authors:

Anna A Mensah, MSc; Helen Campbell, PhD;  Julia Stowe, PhD; Giulia Seghezzo, MSc; Ruth Simmons, PhD; Joanne Lacy, MSc; Antoaneta Bukasa, MSc; Shennae O'Boyle, MSc; Mary E Ramsay, FFPH; Kevin Brown, FRCPath & Shamez N Ladhani, PhD

 

Published:

The Lancet, 28 March 2022 (Open Access)

https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00059-1/fulltext

 

Summary

Background

Background Reinfection after primary SARS-CoV-2 infection is uncommon in adults, but little is known about the risks, characteristics, severity, or outcomes of reinfection in children. We aimed to assess the risk of SARS-CoV-2 reinfection in children and compare this with the risk in adults, by analysis of national testing data for England.

The Korea Herald, 29 April 2020 - Tests in recovered patients found false positives, not reinfections, experts say

Title:
Tests in recovered patients found false positives, not reinfections, experts say

Author:
Kim Bo-gyung

Published:
The Korea Herald, 29 April 2020 

From the article:
"South Korea’s infectious disease experts said Thursday that dead virus fragments were the likely cause of over 260 people here testing positive again for the novel coronavirus days and even weeks after marking full recoveries.  

Oh Myoung-don, who leads the central clinical committee for emerging disease control, said the committee members found little reason to believe that those cases could be COVID-19 reinfections or reactivations, which would have made global efforts to contain the virus much more daunting."

To read this article:
http://www.koreaherald.com/view.php?ud=20200429000724

Scholarly Article (The Lancet, 27 April 2020) - What policy makers need to know about COVID-19 protective immunity.

Title:
What policy makers need to know about COVID-19 protective immunity

Authors:
Daniel M. Altmann, Daniel C. Douek & Rosemary J. Boyton

Published:
The Lancet, 27 April 2020
Available: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30985-5/fulltext

From the article:
"About a third of the world is under lockdown as a public health measure to curb the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). Policy makers are increasingly pressed to articulate their rationales and strategies for moving out of lockdown; the process of re-emergence is already cautiously starting in Austria, Switzerland, Denmark, Wuhan, and some US states. As the counterpoise between further disease spread and socioeconomic costs is debated, it is essential that policy makers in all affected countries have the best possible data and understanding to inform any course of action."